BioCentury
ARTICLE | Company News

Gilead sales and marketing update

July 20, 2015 7:00 AM UTC

The German Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that “a hint of non-quantifiable added benefit” was found in a subset of HCV patients being treated ...